White & Case advises Groupe Industriel Marcel Dassault on private placement of bioMérieux shares

Global law firm White & Case LLP has advised Groupe Industriel Marcel Dassault (GIMD), a holding company controlled by the Dassault family, and its subsidiary SITAM Belgique on the sale of 940,000 shares in bioMérieux, representing approximately 0.8 percent of bioMérieux's share capital.

bioMérieux is a world leader in the field of in vitro diagnostics and is listed on the regulated market of Euronext Paris.

The disposal was carried out via an institutional private placement to qualified investors by way of an accelerated bookbuilding. Following this placement, GIMD retains 3 percent of the share capital of bioMérieux and its representation on bioMérieux's board of directors.

The placement was managed by BNP Paribas as sole global coordinator and sole bookrunner.

The White & Case team in Paris which advised on the transaction was led by partner Thomas Le Vert and included partner Max Turner and associates Boris Kreiss and Jaime Lee.

Press contact
For more information please speak to your local media contact.